Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool August 25, 2010 Jim Mueller	How Did You Manage That, Chesapeake Energy? Here's a look at what Chesapeake Energy, a natural gas producer, has done with its earnings over the past few years.
The Motley Fool August 26, 2010 Jim Mueller	How Did You Manage That, Huntington Bancshares? Here's a look at how Huntington Bancshares, a regional bank, has done over the past few years with earnings, compared to a couple of other businesses playing in the same space.
The Motley Fool August 26, 2010 Jim Mueller	How Did You Manage That, Starbucks? Here's a look at how the earnings pattern of Starbucks, the coffee purveyor, has done over the past few years.
The Motley Fool August 25, 2010 Jim Mueller	How Did You Manage That, Cliffs Natural Resources? Let's look at the earnings pattern of Cliffs Natural Resources, an iron and coal miner.
The Motley Fool August 26, 2010 Jim Mueller	How Did You Manage That, Las Vegas Sands? Here's a look at casino operator Las Vegas Sands earning pattern over the past few years.
The Motley Fool June 24, 2009 Brian Orelli	The Death of a Cash Cow The company knew a drop in Roundup sales was coming with the patent expiring, but Monsanto has a backup plan.
The Motley Fool January 6, 2010 Brian Orelli	Monsanto Needs to Round Up Some Growth Monsanto announces a $0.03 first-quarter loss compared with $1.00 per share of income a year ago. That's not exactly starting the year off on the right foot.
The Motley Fool March 10, 2009 David Lee Smith	Dow's Headed Down the Aisle The purchase of Rohm and Haas by Dow Chemical, a saga that has seemingly lasted nigh onto forever, is over.
The Motley Fool January 28, 2005 Rich Smith	The Tao of Dow Overall, and despite a slew of one-time benefits and charges that skew the results somewhat, Dow Chemical managed to increase its profits by 57% in comparison to its 2003 results, earning its shareholders $2.93 per diluted share in 2004.
The Motley Fool June 29, 2010 Brian Orelli	Foolish Forecast: Monsanto 2.0 With Monsanto's herbicide Roundup facing cheap generic competition, the agriculture giant has planted its hopes for growth solely in the field of biotech seeds.
The Motley Fool October 28, 2011 David Lee Smith	Dow Chemical Shows Shocking Strength Dow Chemical's share-price U-turn indicates a surprisingly strong quarter.
The Motley Fool January 19, 2010 Brian Orelli	Monsanto's Legal Wins Are Just the Beginning The lawyers may affect the stock price for a while.
The Motley Fool December 15, 2009 Brian Orelli	Why Does Everyone Hate Monsanto? Sometimes the mean guy wins.
The Motley Fool September 11, 2009 Brian Orelli	Monsanto Plowed Down Is it bad news, or a bad-news buy?
The Motley Fool March 31, 2004 W.D. Crotty	Monsanto in the Balance Genetically modified crops are a boon for the company.
The Motley Fool August 20, 2009 Brian Orelli	Monsanto Fights Back Monsanto and DuPont have escalated their squabble over DuPont's license of Monsanto's Roundup Ready gene.
The Motley Fool October 27, 2005 W.D. Crotty	One Word: Plastics Dow Chemical reports hearty sales growth for the third quarter. But there is a lot more for long-term investors to investigate.
The Motley Fool October 11, 2010 Jeremy Phillips	Reasons to Sell Monsanto Today We're seeking danger signs among Fools' most beloved stocks.
The Motley Fool October 29, 2007 David Lee Smith	Where Are You Going, Dow Chemical? While Dow Chemical reported a down quarter, the real question investors need to ask is its likely direction.
The Motley Fool June 26, 2007 Rich Duprey	Foolish Forecast: Monsanto's Monstrous Growth Agricultural products company Monsanto will report third-quarter 2007 financial results on Thursday. Will investors on the sidelines be green with envy?
The Motley Fool January 22, 2008 Anders Bylund	DuPont Is on Point: Fool by Numbers The fast facts on DuPont's fiscal 2007 earnings, in which the chemical company reported five straight years of increasing return on invested capital.
The Motley Fool August 6, 2009 Brian Orelli	No More Flower Power for Monsanto Monsanto sells its sunflower business to rival Syngenta for $160 million.
The Motley Fool February 27, 2009 Brian Orelli	Hooray for Stalemates! Government deadlock will likely bring more genetically engineered seeds to the EU, and good news for Syngenta, DuPont, and Dow Chemical.
The Motley Fool December 6, 2011 Neha Chamaria	Debugging Monsanto's Bug Concerns Doubts about Monsanto's pest-resistant seeds' efficiency grow. Should you become cautious?
The Motley Fool September 17, 2010 Dave Mock	3 Reasons to Sell Monsanto Today Monsanto faces serious competitive threats on several fronts, threats that could continue to pressure the stock.
The Motley Fool August 20, 2008 Brian Orelli	A Moooving Acquisition Eli Lilly buys Monsanto's cow hormone business.
The Motley Fool January 15, 2010 Brian Orelli	Monsanto Rounds Up Documents for the DOJ The government investigates the agriculture giant.
The Motley Fool September 3, 2008 Brian Orelli	Monsanto's Public-Relations Nightmare Agriculture giant Monsanto has to defend its patents without looking like it's picking on the little guy.
The Motley Fool April 29, 2010 David Lee Smith	Don't Tell Dow Chemical the Economy Is Soft Dow Chemical, a short time from its wild 2009, turns in one powerful quarter.
The Motley Fool October 27, 2010 David Lee Smith	DuPont's Decline Was Patently Explainable While DuPont saw declining earnings, its future continues to brighten.
The Motley Fool December 7, 2007 David Lee Smith	Dow Chemical's Not a Dazzler Yet Dow Chemical is planning a cost-reduction effort that will involve shutting down a number of plants and laying off about 1,000 employees, but the company's direction remains a mystery.
The Motley Fool January 11, 2012 Jacob Roche	Betting the Farm on Monsanto The biotech giant sits at the top of the food chain.
The Motley Fool July 15, 2010 Brian Orelli	Insider Buying at Monsanto Monsanto's CEO and CFO bought shares. Should you?
The Motley Fool January 4, 2008 Brian Orelli	Monsanto Rounds Up Growth Sales grew 36% year-over-year at Monsanto; since sales growth significantly outpaced costs, the bottom line looked even better, with diluted EPS nearly tripling.
The Motley Fool September 16, 2008 Brian Orelli	Monsanto's Guidance Keeps Growing Monsanto announces another change in financial guidance, which fortunately continued the upward trend.
The Motley Fool July 29, 2010 David Lee Smith	Under New Management, DuPont Cruises Ellen Kullman, who has been DuPont's CEO since 2008, has breathed life into a previously lackluster company.
The Motley Fool January 6, 2012 Neha Chamaria	Dow's Wow Performance in 2011 Great operational performance and growth moves, but subdued stock performance wraps up the year for Dow Chemical.
The Motley Fool July 21, 2004 Rich Smith	Whirlpool Hums Along Does the company's latest report signal a prime buying opportunity?
The Motley Fool August 20, 2011 Rex Moore	Could Monsanto Be Hiding Weakness? There is a yellow flag concerning Monsanto's goodwill and intangible assets.
The Motley Fool September 2, 2010 Anand Chokkavelu	Is DuPont Stock Cheap Right Now? Here's how DuPont compares it its peers for trailing five-year growth.
The Motley Fool January 23, 2006 Rich Smith	Foolish Forecast: Divining DuPont DuPont sports a trailing P/E of 18, but beware. On a free cash flow basis, this company's positively acidic, with a price-to-free cash flow ratio of 33.
The Motley Fool May 28, 2009 Brian Orelli	Monsanto Plowed Down Low end of guidance is better than lowered guidance, I guess.
The Motley Fool October 26, 2004 W.D. Crotty	DuPont Banks Shiny Quarters DuPont has its third consecutive quarter of higher revenue and earnings.
The Motley Fool October 22, 2009 David Lee Smith	DuPont Clobbers the Street's Estimates Chemical giant DuPont grew its earnings and proves that the recession might be waning.
The Motley Fool November 22, 2010 Seth Jayson	Are Monsanto's Earnings Worse Than They Look? With 27.8% of operating cash flow coming from questionable sources, Monsanto investors should take a closer look at the underlying numbers.
The Motley Fool November 3, 2005 Rich Smith	Investors Ignore Sportsman's Guide Outdoor specialist still on track. But investors need to keep an eye on some yellow flags in future quarters.
The Motley Fool June 26, 2008 Brian Orelli	Why Throw Tomatoes at Monsanto? There wasn't a lot to complain about in Monsanto's third-quarter earnings report, but investors found enough disappointing news to send the stock down.
The Motley Fool July 21, 2009 Brian Orelli	Monsanto and Dow Create Super Corn Sometimes you need a little help from a friend.
The Motley Fool October 8, 2009 Toby Shute	Monsanto's Solid Year in Seeds The agriculture giant closes the books on a fine year and looks forward.
The Motley Fool December 14, 2010 David Lee Smith	Dow Chemical's A Worldwide Wonder Again Here's hoping you haven't missed Dow Chemical's growing global successes.